Eagle Meds Services
Eltrombopag (Eltrombopag Olamine)
Available to sourceHuman Prescription DrugOncology & Specialty

Eltrombopag (Eltrombopag Olamine)

25 mg/1 · Tablet
By Hikma Pharmaceuticals USA Inc.
NDC
0054-0963
Route
Oral
Therapeutic class
Breast Cancer Resistance Protein Inhibitors [MoA], Increased Megakaryocyte Maturation [PE], Increased Platelet Production [PE], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Thrombopoietin Receptor Agonist , Thrombopoietin Receptor Agonists [MoA], UGT1A1 Inhibitors [MoA], UGT1A3 Inhibitors [MoA], UGT1A4 Inhibitors [MoA], UGT1A6 Inhibitors [MoA], UGT1A9 Inhibitors [MoA], UGT2B15 Inhibitors [MoA], UGT2B7 Inhibitors [MoA]
Marketing category
ANDA

Package sizes

  • 30 TABLET in 1 BOTTLE (0054-0963-13)NDC 0054-0963-13Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Eltrombopag (Eltrombopag Olamine)
NDC 0054-0963